IJMSRT foster a global community of researchers and provide them with a platform to publish and access high-quality scientific content. We strive to be at the forefront of scientific communication, enabling the rapid dissemination of cutting-edge research and driving advancements in various fields.
Read moreAbstract Background: Chronic kidney disease (CKD) is a growing public health burden in many low and middle-income countries including Nigeria. This study evaluated demographic, socio-economic, and anthropometric data, as well as results of traditional clinical diagnostic tests among chronic kidney disease patients living with hypertension and diabetes in EkitiState, Nigeria. Methods: A cross-sectional study was conducted among 270 adult participants. Participants were grouped based on their eGFR values into CKD stage 1 (n=29), CKD stage 2 (n=41), CKD stage 3 (n=35), CKD stage 4 (n=15), CKD stage 5 (n=50), and Control (n=100). Demographic, socio-economic, and anthropometric data, as well as serum urea and creatinine values were analyzed. Results: Participants in CKD stage 5 (73.50 ± 5.64) were significantly older compared to those in CKD stage 1 (50.10 ± 6.20) (F=31.42, p<0.001). Low-income earners (<₦30,000/month) comprised 64.0% of participants in CKD stage 5 compared to 22.0% of controls (χ²=38.12, p<0.001). Participants with combined hypertension and diabetes had the most severe clinical profiles, with mean systolic blood pressure of 162.40 ± 18.50mmHg, serum urea of 14.60 ± 6.80 mmol/L, serum creatinine of 284.60 ± 112.40 µmol/L, and eGFR of 28.60 ± 16.40 mL/min/1.73m² (p<0.001). Socio-economic indices correlated positively with eGFR (r=+0.458, p<0.001) and negatively with serum creatinine (r=-0.436, p<0.001). Conclusion: Low socio-economic status, advancing age, and dual burden of hypertension and diabetes drive progression of renal impairment among CKD patients in Ekiti-State. Standard creatinine estimation misses early-stage decline, highlighting the urgent need for routine eGFR reporting and subsidized medical testing.
REFERENCES
[1]. Elendu C, Elendu RC, Enyong JM, Ibhiedu JO, Ishola IV, Egbunu EO, Meribole ES, Lawal SO, Okenwa CJ, Okafor GC, Umeh ED, Mutalib OO, Opashola KA, Fatoye JO, Awotoye TI, Tobih-Ojeanelo JI, Ramon-Yusuf HI, Olanrewaju A, Afuh RN, Adenikinju J, Amosu O, Yusuf A. Comprehensive review of current management guidelines of chronic kidney disease. Medicine (Baltimore). 2023 Jun 9;102(23):e33984. doi: 10.1097/MD.0000000000033984
[2]. Ndubuisi NE. Noncommunicable Diseases Prevention In Low- and Middle-Income Countries: An Overview of Health in All Policies (HiAP). Inquiry. 2021 Jan-Dec;58:46958020927885. doi: 10.1177/0046958020927885
[3]. Qi Q, Hu Y, Shen Q, Tang K, Yu J, Xu Y, Huang Q, Hou B, Hao Z. Global, regional, and national burden of chronic kidney disease and its associated anemia, 1990 to 2021 and predictions to 2050: an analysis of the global burden of disease study 2021. BMC Nephrol. 2025 Aug 27;26(1):495. doi: 10.1186/s12882-025-04398-4
[4]. Ovwasa H, Aiwuyo HO, Okoye A OC, Unuigbe E, Rajora N. Epidemiology Trend of Chronic Kidney Disease in a SemiUrban Tertiary Hospital in Sub-Saharan Africa. Cureus. 2023 Mar 30;15(3):e36912. doi: 10.7759/cureus.36912
[5]. Gadelkareem RA, Abdelgawad AM, Mohammed N, Zarzour MA, Khalil M, Reda A, Hammouda HM. Challenges to establishing and maintaining kidney transplantation programs in developing countries: What are the coping strategies? World J Methodol. 2024 Jun 20;14(2):91626. doi: 10.5662/wjm.v14.i2.91626
[6]. Qasim H, Ktaifan M, Awawdeh A, Khattab K, Leoni MLG, Varrassi G. Hypertensive Nephrosclerosis: Pathological Changes and Overlap with Diabetic Nephropathy. Cureus. 2025 Sep 22;17(9):e92949. doi: 10.7759/cureus.92949
[7]. Wang M, Li J, Li Y, Yao S, Zhao M, Wang C, Wu S, Xue H. The effects of hypertension and diabetes on new-onset chronic kidney disease: A prospective cohort study. J Clin Hypertens (Greenwich). 2020 Jan;22(1):39-46. doi: 10.1111/jch.13768
[8]. Kakkad N, Shah S, Parmar N, Patel J, Rabadiya KD. Assessment of risk factors associated with common chronic diseases in an adult population. Bioinformation. 2026 Feb 28;22(2):839-845. doi: 10.6026/973206300220839
[9]. Barakat C, Konstantinidis T. A Review of the Relationship between Socioeconomic Status Change and Health. Int J Environ Res Public Health. 2023 Jun 29;20(13):6249. doi: 10.3390/ijerph20136249
[10]. Gounden V, Bhatt H, Jialal I. Renal Function Tests. [Updated 2024 Jul 27]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507821/
[11]. Akpor OA, Adeoye AO, Ibitoba FA, Akpor OB. Prevalence of Chronic Kidney Disease Among Diabetes and Hypertensive Patients in a Teaching Hospital in Ekiti State, Southwest Nigeria. Open Public Health J. 2022 Dec 30;15:e187494452212201. doi: 10.2174/18749445-v15-e221220-2022-99
[12]. Vaidya SR, Aeddula NR. Chronic Kidney Disease. [Updated 2024 Jul 31]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK535404/
[13]. Shah MU, Roebuck A, Srinivasan B, Ward JK, Squires PE, Hills CE, Lee K. Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations. Front Endocrinol (Lausanne). 2025 Jan 22;15:1499681. doi: 10.3389/fendo.2024.1499681
[14]. Ipinnimo TM, Adewoye KR, Durowade KA, Elegbede OE, Ojo JO, Dele-Ojo BF, Oluwademilade OJ, Atoyebi OA, Sanni TA, Asake OT, Daramola BW, Fadipe AO. Comparative assessment of health-related quality of life among hypertensive patients attending state and federal government teaching hospitals in Ekiti State, Nigeria. Dialogues Health. 2022 Nov 2;1:100069. doi: 10.1016/j.dialog.2022.100069
[15]. Ibrahim AO, Udonwa N, Oku AO, Aremu SK, Akinola YO, Mushau OO, Ajetunmobi OA, Afolayan OF, Gabriel-Alayode OE, Ajetunmobi WA. Blood Pressure Control and its Barriers among Adult Rural Dwellers Living with Hypertension in Ido-Osi Communities of Ekiti State, Southwest Nigeria. J. Adv. Med. Med. Res. [Internet]. 2026 Mar. 5 [cited 2026 Aug. 20];38(3):1-15. Available from: https://journaljammr.com/index.php/JAMMR/article/view/6087
[16]. Steenkamp V, Stewart MJ. Nephrotoxicity associated with exposure to plant toxins, with particular reference to Africa. Ther Drug Monit. 2005 Jun;27(3):270-7. doi: 10.1097/01.ftd.0000162229.86303.67
[17]. Clyne N, Anding-Rost K. Exercise training in chronic kidney disease-effects, expectations and adherence. Clin Kidney J. 2021 May 6;14(Suppl 2):ii3-ii14. doi: 10.1093/ckj/sfab012
[18]. Martínez-Montoro JI, Morales E, Cornejo-Pareja I, Tinahones FJ, Fernández-García JC. Obesity-related glomerulopathy: Current approaches and future perspectives. Obes Rev. 2022 Jul;23(7):e13450. doi: 10.1111/obr.13450
[19]. Cheng TC, Huang SH, Kao CL, Hsu PC. Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical ImplicationsA Narrative Review. Int J Mol Sci. 2022 May 27;23(11):6047. doi: 10.3390/ijms23116047
[20]. Quiñones J, Hammad Z. Social Determinants of Health and Chronic Kidney Disease. Cureus. 2020 Sep 5;12(9):e10266. doi: 10.7759/cureus.10266
[21]. Pandya D, Nagrajappa AK, Ravi KS. Assessment and Correlation of Urea and Creatinine Levels in Saliva and Serum of Patients with Chronic Kidney Disease, Diabetes and Hypertension- A Research Study. J Clin Diagn Res. 2016 Oct;10(10):ZC58-ZC62. doi: 10.7860/JCDR/2016/20294.8651
[22]. Ogueze AC, Mbachu NA, Ihim AC, Onah EC, Nwoka NC, Okeke SC, Akaeme JC, Nduka CF. Evaluation of Some Renal Biomakers in Patients with Benign Prostatic Hyperplasia/Prostate Cancer Attending Nnamdi Azikiwe University Teaching Hospital Nnewi. Int J Res Innov Appl Sci. 2024 Sep 10;9(8):413-421. doi: 10.51584/IJRIAS.2024.908036
Chronic kidney disease, Socio-economic status, Risk factors, Hypertension, Diabetes, Nigeria.
Note : A published paper may take 4-5 working days from the publication date to appear in Rode, Semantic Scholar, and open alex.
